1Fellous A,Meininger V,Binet S,et al.Action of navelbiae(NVB) on microtubules_Role of Tan MAP proteins.[M]// Pierre Fabre Oncologie eds.Navebine:update and new trends.France:John Libbey Eurotext Ltd,1991:9.
2Potier P.History of the discory of navelbine.[M]//Pirre Fabre Oncologic eds.Navelbine:upte and new trends.France:John Libbey Eurotext Ltd,1991:4.
3Adams D J,Knick V C.P-glicoprotein mediated resistence to 5'-nor-anhydrovinblastine(Navelbine)[J].Invest New Drugs,1995,13(1):13-21.
4Finkelstein D M,Ettinger D S,Ruckdeschei J C.Long-term survivors in metastatic non-small cell lung cancer:.An Easterm Cooperative Gronp Study[J].J Clin Oncol,1986,4(5):861-865.
5Bonomi P D,Finkelstein P M,Ruckdeschel J C,et al.Combination chemotherapy versus single agents followed by combination chemotherapy in stage Ⅳ non-small cell lung cancer.A study of the Eastem Cooperative Oncology Groud[J].J Clin Oncol,1989,7(11):1602-1613.
6Rigas J R,Kris M G,Roth J A,et al.New chemotherapeutic agents in lung cancer[M]//Lung Cancer.Boston:Bianckwill Scientisic Publications,1993:252-269.
7Preti P,Poggi G,Cuomo A M,et al.Phase Ⅱ stuty with ifosfamide,carboplatin,etoposide (ICE regimen) at intermediate dosage for advanced non-small lung cancer (NSCLC)[J].J Chemother,1998,10(6):492-495.
8Chang A Y,Asbury R F,Boros L,et al.Ifosfamide/carboplatin/etoposide chemotherapy in patient with metastatic non-small cell lung cancer[J].Semin Oncol,1995,22(3 Suppl 7):9-12.
